FJX1 and melanoma: The latest research showed that FOXD3-AS1 targets the miR-127-3p/FJX1 axis in melanoma progression (120) and FJX1 facilitates cell proliferation and motility in colon adenocarcinoma by inhibiting miR‐1249 (121, 122).